BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3340456)

  • 1. Sepsis in febrile neutropenic children with cancer.
    Langley J; Gold R
    Pediatr Infect Dis J; 1988 Jan; 7(1):34-7. PubMed ID: 3340456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.
    Rubin M; Hathorn JW; Marshall D; Gress J; Steinberg SM; Pizzo PA
    Ann Intern Med; 1988 Jan; 108(1):30-5. PubMed ID: 3337513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
    Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
    Krediet TG; Jones ME; Gerards LJ; Fleer A
    Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial spectrum of blood and body cultures in febrile episodes of children under chemotherapy for treatment of malignant diseases.
    Göbel V; Jürgens H; Thomas L; Schwamborn D; Rosin H; Göbel U
    Pediatr Hematol Oncol; 1987; 4(1):7-13. PubMed ID: 3152914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of tobramycin-resistant S. epidermidis possessing aminoglycoside modifying enzymes and bacteremic superinfection during empiric therapy of febrile neutropenic episodes.
    Riben PD; Horsman GB; Rayner E; Irvine-Meek J; Urias B; Albritton WL; deSaxe MJ; Ronald AR; Louie TJ
    Clin Invest Med; 1985; 8(4):272-85. PubMed ID: 3907919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia.
    Piccart M; Klastersky J; Meunier F; Lagast H; Van Laethem Y; Weerts D
    Antimicrob Agents Chemother; 1984 Dec; 26(6):870-5. PubMed ID: 6524903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
    Menichetti F; Del Favero A; Bucaneve G; Aversa F; Fiorio M
    Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
    Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
    Khan MA; Siddiqui BK; Shamim A; Yosuf MA; Ahmed U; Zakiullah N; Burney IA
    J Pak Med Assoc; 2004 Jul; 54(7):357-60. PubMed ID: 15449917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of empiric vancomycin therapy in children with fever and neutropenia.
    Adcock KG; Akins RL; Farrington EA
    Pharmacotherapy; 1999 Nov; 19(11):1315-20. PubMed ID: 10555937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors].
    Natali M; Tonini G; Tufo E; Leggio M; Carassai A; Lopez M
    Clin Ter; 1989 Sep; 130(5):239-44. PubMed ID: 2530024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of bacteriologic cultures in choice of antibiotics in patients with chemotherapy-induced neutropenic sepsis.
    Leong SS; Ang PT
    Ann Acad Med Singap; 1997 Jul; 26(4):439-42. PubMed ID: 9395806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology of septicemia in children with acute leukemia: 9-year experience from a children's hospital in China.
    Ye Q; Xu X; Zheng Y; Chen X
    J Pediatr Hematol Oncol; 2011 Jul; 33(5):e186-91. PubMed ID: 21617561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspected infection in children with cancer.
    Jones PD; Henry RL; Stuart J; Francis L
    J Qual Clin Pract; 1998 Dec; 18(4):275-84. PubMed ID: 9862664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L; Wells H; Lange BJ
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.